Journal of the Practice of Cardiovascular Sciences

JOURNAL CLUB
Year
: 2019  |  Volume : 5  |  Issue : 3  |  Page : 154--156

Platelet Blockage: Prasugrel versus Ticagrelor: Intracoronary Stenting and Antithrombotic Regimen: Rapid Early Action for Coronary Treatment 5


Venkatakrishnan Ramakumar 
 Department of Cardiology, AIIMS, New Delhi, India

Correspondence Address:
Dr. Venkatakrishnan Ramakumar
Department of Cardiology, AIIMS, New Delhi
India

The Intracoronary Stenting and Antithrombotic Regimen: Rapid Early Action for Coronary Treatment 5 trial randomized patients with acute coronary syndrome for whom invasive treatment was planned to ticagrelor versus prasugrel. At 1-year, prasugrel was associated with a 2.4% absolute reduction in the primary outcome. The trial suggests that prasugrel may be superior to ticagrelor in reducing the thrombotic outcomes. It could be that once daily dosing with prasugrel and higher rate of drug discontinuation in the ticagrelor group may be the mechanism.


How to cite this article:
Ramakumar V. Platelet Blockage: Prasugrel versus Ticagrelor: Intracoronary Stenting and Antithrombotic Regimen: Rapid Early Action for Coronary Treatment 5.J Pract Cardiovasc Sci 2019;5:154-156


How to cite this URL:
Ramakumar V. Platelet Blockage: Prasugrel versus Ticagrelor: Intracoronary Stenting and Antithrombotic Regimen: Rapid Early Action for Coronary Treatment 5. J Pract Cardiovasc Sci [serial online] 2019 [cited 2020 Feb 27 ];5:154-156
Available from: http://www.j-pcs.org/article.asp?issn=2395-5414;year=2019;volume=5;issue=3;spage=154;epage=156;aulast=Ramakumar;type=0